GUOSF yields 3.00% · PFE yields 6.13%● Live data
📍 GUOSF pulled ahead of the other in Year 1
Combined, GUOSF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of GUOSF + PFE for your $10,000?
Guotai Junan Securities Co., Ltd. provides various financial services for individuals and institutional clients in Mainland China, Hong Kong, and internationally. It operates through Wealth Management Business, Investment Banking Business, Institutional and Trading Business, Investment Management Business, and International Business segments. The company offers securities and futures brokerage, financial products, investment advisory, margin financing and securities lending, securities repurchase, and stock pledging and other services; listing sponsorship, equity underwriting, debt underwriting, structured debt financing, M&A financial advisory, and diversified corporate solutions to corporate and governmental clients; institutional brokerage, trading, investment and equity investment, seat leasing, custody and outsourcing, QFII, and other services; and investment transactions in stocks, fixed income, foreign exchange, and commodities and their derivative financial instruments, as well as integrated financial solutions for clients' investment, financing, and risk management. It also provides asset management and fund management services; and brokerage, corporate finance, asset management, and loans and financing services, as well as financial products, and market making and investment services. In addition, the company offers real estate and property management, warehouse service, corporate management consulting, venture capital investment and management, investment management, industrial investment, and investment consulting services. The company was founded in 1992 and is based in Shanghai, China.
Full GUOSF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.